Search research articles
Contact Us
Filters
Showing results (21-30 of 152) with videos related to
Page
of 16
Sort By:
Epilepsia
|
November 17, 2012
The borderland of epilepsy: Chairs' Symposium, 10th European Congress on Epileptology, London--October 1, 2012. Introduction
Phil Smith, Meir Bialer
Pharmacology & Therapeutics
|
February 8, 2025
From barbiturates to ganaxolone: The importance of chirality in drug development and in understanding the actions of old and new antiseizure medications
Meir Bialer, Emilio Perucca
CNS Drugs
|
June 7, 2020
Critical Aspects Affecting Cannabidiol Oral Bioavailability and Metabolic Elimination, and Related Clinical Implications
Emilio Perucca, Meir Bialer
Epilepsia
|
April 14, 2010
Generic products of antiepileptic drugs: a perspective on bioequivalence and interchangeability
Meir Bialer, Kamal K Midha
Nature Reviews. Drug Discovery
|
January 1, 2010
Key factors in the discovery and development of new antiepileptic drugs
Meir Bialer, H Steve White
CNS Drugs
|
October 5, 2013
Generic products of antiepileptic drugs: a perspective on bioequivalence, bioavailability, and formulation switches using Monte Carlo simulations
Vangelis Karalis, Panos Macheras, Meir Bialer
Current Opinion in Neurology
|
March 20, 2003
New CNS-active drugs which are second-generation valproic acid: can they lead to the development of a magic bullet?
Nina Isoherranen, Boris Yagen, Meir Bialer
Bioorganic & Medicinal Chemistry
|
July 30, 2016
Design and comparative anticonvulsant activity assessment of CNS-active alkyl-carbamoyl imidazole derivatives
Hafiz Mawasi, David Bibi, Meir Bialer
Journal of Medicinal Chemistry
|
August 6, 2004
Tetramethylcyclopropyl analogue of a leading antiepileptic drug, valproic acid. Synthesis and evaluation of anticonvulsant activity of its amide derivatives
Eyal Sobol, Meir Bialer, Boris Yagen
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
August 29, 2013
Quantitative assessment of the switchability of generic products
Vangelis Karalis, Meir Bialer, Panos Macheras
Page
of 16
Search research articles
Search
Showing results (21-30 of 152) with videos related to
Sort By:
Page
of 16
Epilepsia
|
November 17, 2012
The borderland of epilepsy: Chairs' Symposium, 10th European Congress on Epileptology, London--October 1, 2012. Introduction
Phil Smith, Meir Bialer
Pharmacology & Therapeutics
|
February 8, 2025
From barbiturates to ganaxolone: The importance of chirality in drug development and in understanding the actions of old and new antiseizure medications
Meir Bialer, Emilio Perucca
CNS Drugs
|
June 7, 2020
Critical Aspects Affecting Cannabidiol Oral Bioavailability and Metabolic Elimination, and Related Clinical Implications
Emilio Perucca, Meir Bialer
Epilepsia
|
April 14, 2010
Generic products of antiepileptic drugs: a perspective on bioequivalence and interchangeability
Meir Bialer, Kamal K Midha
Nature Reviews. Drug Discovery
|
January 1, 2010
Key factors in the discovery and development of new antiepileptic drugs
Meir Bialer, H Steve White
CNS Drugs
|
October 5, 2013
Generic products of antiepileptic drugs: a perspective on bioequivalence, bioavailability, and formulation switches using Monte Carlo simulations
Vangelis Karalis, Panos Macheras, Meir Bialer
Current Opinion in Neurology
|
March 20, 2003
New CNS-active drugs which are second-generation valproic acid: can they lead to the development of a magic bullet?
Nina Isoherranen, Boris Yagen, Meir Bialer
Bioorganic & Medicinal Chemistry
|
July 30, 2016
Design and comparative anticonvulsant activity assessment of CNS-active alkyl-carbamoyl imidazole derivatives
Hafiz Mawasi, David Bibi, Meir Bialer
Journal of Medicinal Chemistry
|
August 6, 2004
Tetramethylcyclopropyl analogue of a leading antiepileptic drug, valproic acid. Synthesis and evaluation of anticonvulsant activity of its amide derivatives
Eyal Sobol, Meir Bialer, Boris Yagen
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
August 29, 2013
Quantitative assessment of the switchability of generic products
Vangelis Karalis, Meir Bialer, Panos Macheras
Page
of 16